FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124807922> ?p ?o ?g. }

• W2124807922 endingPage "8" @default.
• W2124807922 startingPage "1" @default.
• W2124807922 abstract "The Polo-like kinase 1 (Plk1) plays a key role in regulating a broad spectrum of critical cell cycle events. Plk1 is a marker of cellular proliferation and has prognostic potential in different types of human tumors. In a series of preclinical studies, Plk1 has been validated as a cancer target. This prompted many pharmaceutical companies to develop small-molecule inhibitors targeting the classical ATP-binding site of Plk1 for anticancer drug development. Recently, FDA has granted a Breakthrough Therapy designation to the Plk inhibitor BI 6727 (volasertib), which provided a survival benefit for patients suffering from acute myeloid leukemia. Remarkably, a new generation of Plk1 inhibitors that target the second druggable domain of Plk1, the Polo-box domain, is currently being tested preclinically. Since various ATP-competitive compounds of Plk1 inhibit also the activities of Plk2 and Plk3, which act as tumor suppressors, the roles of closely related Plk-family members in cancer cells need to be considered carefully. In this article, the authors highlight recent insights into the biology of Plks in cancer cells and discuss the progress in the development of small-molecule Plk1 inhibitors. The authors believe that the greatest therapeutic benefit might come through leukemic cells that are in direct contact with the inhibitor in the blood stream. The identification of biomarkers and studies that document Plk activities in treated patients would also be beneficial to better understand the role of Plk inhibition in tumor development and anticancer therapy." @default.
• W2124807922 created "2016-06-24" @default.
• W2124807922 creator A5001105399 @default.
• W2124807922 creator A5019378375 @default.
• W2124807922 creator A5033962209 @default.
• W2124807922 date "2014-09-29" @default.
• W2124807922 modified "2023-09-25" @default.
• W2124807922 title "Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery" @default.
• W2124807922 cites W114219100 @default.
• W2124807922 cites W1971936302 @default.
• W2124807922 cites W1975776530 @default.
• W2124807922 cites W1979005464 @default.
• W2124807922 cites W1994652412 @default.
• W2124807922 cites W2001213181 @default.
• W2124807922 cites W2006401070 @default.
• W2124807922 cites W2009931781 @default.
• W2124807922 cites W2011953594 @default.
• W2124807922 cites W2016999029 @default.
• W2124807922 cites W2025540821 @default.
• W2124807922 cites W2026609683 @default.
• W2124807922 cites W2051210198 @default.
• W2124807922 cites W2053738387 @default.
• W2124807922 cites W2058727957 @default.
• W2124807922 cites W2061646337 @default.
• W2124807922 cites W2065243832 @default.
• W2124807922 cites W2082087067 @default.
• W2124807922 cites W2090342546 @default.
• W2124807922 cites W2098345116 @default.
• W2124807922 cites W2101725260 @default.
• W2124807922 cites W2103593354 @default.
• W2124807922 cites W2107353013 @default.
• W2124807922 cites W2116282691 @default.
• W2124807922 cites W2117827532 @default.
• W2124807922 cites W2123592667 @default.
• W2124807922 cites W2124998586 @default.
• W2124807922 cites W2126439909 @default.
• W2124807922 cites W2128201005 @default.
• W2124807922 cites W2136066047 @default.
• W2124807922 cites W2167155183 @default.
• W2124807922 cites W2170002512 @default.
• W2124807922 doi "https://doi.org/10.1517/17460441.2015.962510" @default.
• W2124807922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25263688" @default.
• W2124807922 hasPublicationYear "2014" @default.
• W2124807922 type Work @default.
• W2124807922 sameAs 2124807922 @default.
• W2124807922 citedByCount "29" @default.
• W2124807922 countsByYear W21248079222015 @default.
• W2124807922 countsByYear W21248079222016 @default.
• W2124807922 countsByYear W21248079222017 @default.
• W2124807922 countsByYear W21248079222018 @default.
• W2124807922 countsByYear W21248079222019 @default.
• W2124807922 countsByYear W21248079222020 @default.
• W2124807922 countsByYear W21248079222021 @default.
• W2124807922 countsByYear W21248079222022 @default.
• W2124807922 countsByYear W21248079222023 @default.
• W2124807922 crossrefType "journal-article" @default.
• W2124807922 hasAuthorship W2124807922A5001105399 @default.
• W2124807922 hasAuthorship W2124807922A5019378375 @default.
• W2124807922 hasAuthorship W2124807922A5033962209 @default.
• W2124807922 hasConcept C104317684 @default.
• W2124807922 hasConcept C10679952 @default.
• W2124807922 hasConcept C121608353 @default.
• W2124807922 hasConcept C143065580 @default.
• W2124807922 hasConcept C146276462 @default.
• W2124807922 hasConcept C184235292 @default.
• W2124807922 hasConcept C203014093 @default.
• W2124807922 hasConcept C2778461978 @default.
• W2124807922 hasConcept C2778729363 @default.
• W2124807922 hasConcept C2780035454 @default.
• W2124807922 hasConcept C29537977 @default.
• W2124807922 hasConcept C32619005 @default.
• W2124807922 hasConcept C502942594 @default.
• W2124807922 hasConcept C54355233 @default.
• W2124807922 hasConcept C55493867 @default.
• W2124807922 hasConcept C60644358 @default.
• W2124807922 hasConcept C64903051 @default.
• W2124807922 hasConcept C71924100 @default.
• W2124807922 hasConcept C74187038 @default.
• W2124807922 hasConcept C84815855 @default.
• W2124807922 hasConcept C86803240 @default.
• W2124807922 hasConcept C95444343 @default.
• W2124807922 hasConcept C96232424 @default.
• W2124807922 hasConcept C98274493 @default.
• W2124807922 hasConceptScore W2124807922C104317684 @default.
• W2124807922 hasConceptScore W2124807922C10679952 @default.
• W2124807922 hasConceptScore W2124807922C121608353 @default.
• W2124807922 hasConceptScore W2124807922C143065580 @default.
• W2124807922 hasConceptScore W2124807922C146276462 @default.
• W2124807922 hasConceptScore W2124807922C184235292 @default.
• W2124807922 hasConceptScore W2124807922C203014093 @default.
• W2124807922 hasConceptScore W2124807922C2778461978 @default.
• W2124807922 hasConceptScore W2124807922C2778729363 @default.
• W2124807922 hasConceptScore W2124807922C2780035454 @default.
• W2124807922 hasConceptScore W2124807922C29537977 @default.
• W2124807922 hasConceptScore W2124807922C32619005 @default.
• W2124807922 hasConceptScore W2124807922C502942594 @default.
• W2124807922 hasConceptScore W2124807922C54355233 @default.
• W2124807922 hasConceptScore W2124807922C55493867 @default.

• next